Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome

NCT02049229 is registered in ClinicalTrials.gov with The Hospital District of Satakunta as lead sponsor.

NCT NCT02049229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02049229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome
Lead sponsor
The Hospital District of Satakunta
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2014
Completion date
October 31, 2019
Enrollment
1,800 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, myocardial infarction, percutaneous coronary intervention